Mariathasan, Sanjeev
Genentech, Inc,
United States
2025 Rank: 30499
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 582 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30499 | 34127 |
| Total Cites | 2460 | 2621 |
| H-index | 22 | 22 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 774 | 787 |
| Number of Single+First+Last Authored Papers | 20 | 20 |
| Total Cites to Single+First+Last Authored Papers | 1068 | 1103 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2001 | 2084 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
6.14%
|
|
Mariathasan, Sanjeev
Genentech, Inc,
United States
2024 Rank: 26727
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 554 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26727 | 29041 |
| Total Cites | 2609 | 2741 |
| H-index | 20 | 21 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 877 | 887 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 1138 | 1167 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2042 | 2100 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.31 |
| Self-Citation Percentage |
4.82%
|
|
Mariathasan, Sanjeev
Genentech, Inc,
United States
2023 Rank: 37667
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 858 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37667 | 40875 |
| Total Cites | 2648 | 2850 |
| H-index | 18 | 19 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 1006 | 1022 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 1234 | 1267 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2131 | 2214 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.29 |
| Self-Citation Percentage |
7.09%
|
|
Mariathasan, Sanjeev
Genentech Incorporated,
United States
2022 Rank: 31837
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 858 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31837 | 35957 |
| Total Cites | 2428 | 2617 |
| H-index | 18 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 858 | 880 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 1000 | 1026 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1917 | 1990 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.32 |
| Self-Citation Percentage |
7.22%
|
|
Mariathasan, Sanjeev
Genentech Incorporated,
United States
2021 Rank: 40850
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 977 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40850 | 45045 |
| Total Cites | 3119 | 3380 |
| H-index | 18 | 19 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 1117 | 1148 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 1297 | 1328 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2482 | 2582 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.31 |
| Self-Citation Percentage |
7.72%
|
|
Mariathasan, Sanjeev
Genentech Incorporated,
United States
2020 Rank: 39800
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 891 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39800 | 44733 |
| Total Cites | 1904 | 2091 |
| H-index | 15 | 15 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 714 | 742 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 826 | 858 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1528 | 1619 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.29 |
| Self-Citation Percentage |
8.94%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.